OncLive® On Air

OncLive® On Air

Por: OncLive® On Air
In OncLive® On Air, you can expect to hear interviews with academic oncologists on the thought-provoking oncology presentations they give at the OncLive® State of the Science Summits. The topics in oncology vary, from systemic therapies, surgery, radiation therapy, to emerging therapeutic approaches in a particular type of cancer. This includes lung cancer, breast cancer, gastrointestinal cancers, hematologic malignancies, gynecologic cancers, genitourinary cancers, and more.

500 episodios disponibles

Latest episodes of the podcast OncLive® On Air

Mostrando página 21 de 25

S7 Ep35: FDA Approval Insights: Durvalumab Plus Gemcitabine and Cisplatin in Biliary Tract Cancer 03/10/2022
S7 Ep34: Shepard Discusses Symptoms, Management, and Future Directions in Desmoid Tumors 29/09/2022
S7 Ep33: Deol on the Importance of a Well-Rounded Fellowship Experience 26/09/2022
S7 Ep32: Patel Provides Insight Into Post-Transplant Complications in Myeloid Disorders 22/09/2022
S7 Ep31: FDA Approval Insights: Pemigatinib in FGFR1-Rearranged Myeloid/Lymphoid Neoplasms 19/09/2022
S7 Ep30: Leal Sheds Light on Symptoms and Treatment of Lambert-Eaton Myasthenic Syndrome 15/09/2022
S7 Ep29: Elamin Elaborates on Poziotinib in EGFR Exon 20–Mutant NSCLC 12/09/2022
S7 Ep28: Chen Discusses Diagnosis, Management, and Disparities in Cutaneous T-cell Lymphoma 08/09/2022
S7 Ep27: FDA Approval Insights: Trastuzumab Deruxtecan in HER2-Low Unresectable or Metastatic Breast Cancer 05/09/2022
S7 Ep27: Iams and Shah Break Down Lambert-Eaton Myasthenic Syndrome in SCLC and Other Neuroendocrine Cancers 01/09/2022
S7 Ep26: Bekaii-Saab, George, and von Mehren Discuss Pivotal Findings in GIST, TGCT, and RAS/RAF–Mutated Solid Tumors 29/08/2022
S7 Ep25: FDA Approval Insights: Trastuzumab Deruxtecan in HER2-Mutant NSCLC 25/08/2022
S7 Ep24: Petrylak Provides Insight Into Testing, Multidisciplinary Management in Prostate and Bladder Cancer 22/08/2022
S7 Ep24: Goldberg and Sussman Dissect Disparities in Gastric Cancer Mortality Rates 18/08/2022
S7 Ep23: FDA Approval Insights: Darolutamide Plus Docetaxel for Metastatic Hormone-Sensitive Prostate Cancer 15/08/2022
S7 Ep22: Katz Considers the Role of Neoadjuvant Chemoradiation in Borderline Resectable Pancreatic Cancer 11/08/2022
S7 Ep21: Leukemia Experts Reflect on Defining Moments as Women in the Field 08/08/2022
S7 Ep20: Gradishar Stresses the Importance of Accurately Defining Breast Cancer Subtypes 04/08/2022
S7 Ep19: Research Reflections: Subbiah Reviews Striking ASCO 2022 Data Across Oncology 01/08/2022
S7 Ep18: FDA Approval Insights: Liso-Cel in Second-Line Relapsed/Refractory LBCL 28/07/2022
« Primera ‹ Anterior 1 ... 19 20 21 22 23 ... 25 Siguiente › Última »
© 2003-2026 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA